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A B S T R A C T
In the study of 286 patients with suspected coronary artery disease and recent exercise single photon emission com-
puted tomography (SPECT) test, we performed coronary angiography with coronary fractional flow reserve (FFR) mea-
surement and tested the differences between diabetic (103) and non-diabetic (183) patients in ischemia detection by this
two methods. The diabetic patients had a higher prevalence of hypertension, higher BMI and cholesterol levels, as well as
longer duration of hospitalization than non-diabetic patients. There was no difference found between groups according
to the exercise SPECT test, but, there were significantly more negative results in the non-diabetic group than in the dia-
betic group according to the FFR test, also, the percentage of stenosis was higher in diabetic patients. The concordance
between the two methods was found, it was fair in diabetic patients (k=0.25, 95% C.I. 0.06–0.45) and moderate in non-di-
abetic patients (k=0.49, 95 % C.I. 0.36–0.62).
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Introduction
Diabetes mellitus (DM) accelerates the natural devel-
opment of atherogenesis, which on its part results in
structural and functional anomalies of coronary arteries
and microcirculation, with a more frequent occurrence of
ulcerated atherosclerotic plaques, thrombosis and micro-
aneurysms, as well as the absence of adequate vasodi-
latory response1. In such conditions there is often a dis-
crepancy between different non-invasive tests, which
complicates the making of a clinical decision on a further
treatment of the diabetic with the coronary artery dis-
ease (CAD). The ischemic heart disease in patients with
diabetes shows some specificities, such as being fre-
quently of an asymptomatic course and showing nonspe-
cific ECG changes, while coronary atherosclerotic chan-
ges in patients with DM regularly take up a greater
number of branches and spread onto longer segments
that in percutaneous interventions require the implanta-
tion of a greater number of stents. This is why 20–30% of
patients that undergo revascularization by percutaneous
coronary intervention and the implantation of stent suf-
fer of DM, half of whom are treated with insulin2,3. Due
to the frequently irregular values of glucose, diabetics of-
ten suffer of endothelial dysfunction and the consequen-
tial disorder of the microvascular coronary resistance
which can result in the ischemia of the heart muscle or
its hibernation4. Silent ischemia is present in a fifth of di-
abetics who do not show symptoms of CAD5. The per-
centage of patients with DM who have an obvious risk of
worse cardiac outcome is not clear, also whether a solu-
tion can be found for such patients6. Among a range of
non-invasive tests available to cardiologists, myocardial
perfusion imaging techniques such as Technetium-99m-
-labeled sestamibi single-photon emission computed to-
mography (exercise SPECT) are a gold standard in diag-
nosing CAD7. Exercise SPECT is based on the principle
of relative flow reserve, i.e. the fact that hemodynamic
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significant coronary arteries stenoses will signal a re-
gional perfusion deficit. The fractional flow reserve (FFR)
is based on a pressure-flow analysis of the stenosed ar-
tery during the hyperemic (maximal) flow. It is an inva-
sive index that is used to calculate the severity of the in-
vestigated lesion. FFR in normal coronary artery equals
1,0 while an FFR value of less than 0,80 identifies inade-
quate perfusion that causes myocardial ischemia with a
predictive accuracy of more than 90%8. Earlier, FFR was
mainly used in patients with single-vessel coronary ar-
tery disease, while its clinical benefit has nowadays been
confirmed in patients with multivessel coronary artery
disease, in patients with the prior myocardial infarction,
with the main stem disease and in those with function-
ally insignificant stenoses of coronary arteries9–12. Yana-
gisawa and collaborators have confirmed that lower val-
ues of FFR (£0.75) can dependably detect myocardial
ischemia in patients with DM, if, naturally, glycaemic
levels in blood are kept in normal ranges4.
Some studies have shown that exercise SPECT can
confirm CAD with the sensitivity of 90% and specificity
of 70%, but the comparability and concordance of this
method with the FFR values in patients with DM have
not been investigated to the best of our knowledge13.
Methods and Subjects
We enrolled 286 patients who had exercise SPECT
four weeks before the coronary angiography and the FFR
measurement. The patients were divided into a non-dia-
betic (183 patients) and a diabetic (103 patients) group.
The exclusion criteria were: (1) left main stem disease;
(2) chronic total occlusion of one of the coronary arteries
or history of myocardial infarction; (3) acute coronary
syndrome; (4) left ventricular ejection fraction less than
50%; (5) hypersensitivity to adenosine and (6) previous
percutaneous coronary or surgical revascularisation
within 1 month prior to the enrolment. All patients gave
their written informed consent and study obtained the
local ethics committee approval.
Coronary angiography and FFR measurement
Coronarography was perfomed four weeks at most
from the myocardial perfusion imaging – exercise SPECT.
Through 5 or 6 Fr radial artery sheath a diagnostic/guid-
ing catheter was introduced to the ostia of the left and
right coronary arteries. The catheterization was covered
with weight-adjusted dose of unfractioned heparin (100
U/kg). Coronary angiography was performed first, using
standard projections in our institution. FFR measure-
ments were performed using commercially available
0,014-inch pressure guidewires (RADI Medical, Uppsala,
Sweden), which were calibrated and pressure equalised
first. Passing the observed lesion the sensor tipped pres-
sure guidewire was positioned in the distal portion of the
artery. The FFR was calculated from the ratio of mean
distal (distal to the lesion) and mean proximal (aortic)
pressure at the maximal steady state hyperemia. Maxi-
mal vasodilatation (hyperemia) was induced with fast
intracoronary boluses of 140 mg of adenosine. The FFR
threshold value of 0,8 was used to recognize significant
(ischemic) lesions.
Angiographic analysis
Angiograms were analyzed off-line by two independ-
ent operators. Quantitative coronary angiography analy-
sis was performed using the special software (CAAS II
system – Pie Medical Imaging, Maastricht, Netherlands)
and standard parameters as minimal lumen diameter
(MLD), reference diameter, diameter stenosis (DS), per-
centage of stenosis and lesion length were measured. If
posterior descending artery originated from right coro-
nary artery, right dominance was designated and if it
originated from left circumflex artery, left dominance
was designated. In patients with left dominance, four
apical segments were assigned to the anterior descending
artery and inferolateral segments together with inferior
ones were assigned to the left circumflex artery. In pa-
tients with right dominance the apical-inferior segment
was assigned to the right coronary artery and other three
segments to the anterior descending artery. No co-domi-
nant circulation was designated.
SPECT perfusion imaging and interpretation
A two day imaging protocol was performed. Stress
and rest scans were obtained with a 48-hour interval. Ei-
ther a multistage symptom limited exercise test or a
dipyridamole test was performed (one patient underwent
the adenosine test). The dipyridamole dosage was 0,56
mg/kg body weight over 4 minutes. 99mTc sestamibi was
injected at peak exercise or 2 minutes after the dipyrida-
mole infusion. All the patients were injected with a stan-
dard dose of tracer according to the EANM/ESC proce-
dural guidelines for myocardial perfusion imaging which
is 9 MBq/kg (or standard 740 MBq of 99mTc sestamibi).
The gated SPECT was acquired one hour after the tracer
injection with a dual head camera equipped with a low
energy, all purpose, parallel – hole collimator and con-
nected to a dedicated computer system. The acquisition
protocol parameters were the following: 180° rotation
arc, 32 projections, 60 s/projection, 8 frames/heart cycle
and 64x64 matrices. The studies were reconstructed us-
ing filtered back projection without attenuation or scat-
ter correction and realigned along the heart axis. The
stress and rest images were divided according to the 17
standardized myocardial segments and the regional tra-
cer uptake in each segment was semi-quantitatively de-
termined. The defect score was determined by a 2-point
scoring system: 1-no defect, 2-reversible defect.
Statistical analysis
Categorical variables are expressed as frequencies
and relative frequencies; relative frequencies between
the two groups were compared with the c2-test. Continu-
ous variables are expressed as mean and standard devia-
tion; differences between the two groups were compared
with the unpaired t-test. Diagnostic values as sensitivity,
specificity, positive and negative predictive values, posi-
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tive and negative likelihood ratios were calculated for
each group separately in order to compare the two meth-
ods (FFR and MPI). The inter rater agreement coeffi-
cient Kappa was calculated for each group. A p value of
less than 0.05 was considered significant. Data were ana-
lyzed using the MedCalc statistical software, version
11.2.0.0 (MedCalc Inc., Mariakerke, Belgium).
Results
The characteristics of diabetic and non-diabetic pa-
tients are presented in Table 1. The patients with DM
had a higher BMI, a longer duration of hospitalization
and higher cholesterol than non-diabetic patients, and
there were more diabetic patients with hypertension.
FFR data and angiographic data are presented in Ta-
ble 2. The baseline FFR and FFR in hyperemia were sig-
nificantly lower in diabetic patients. Also, the percentage
of stenosis was higher in diabetic patients.
Summary results of FFR and exercise SPECT tests
are presented in Table 3. There were significantly more
positive results in the group with DM than in the group
without DM according to the FFR test. There was no dif-
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TABLE 1
CHARACTERISTICS OF DIABETIC AND NON-DIABETIC PATIENTS
Variable
DM n=103
N (%) or X±SD
non-DM n=183
N (%) or X±SD
Statistics
p
Age 66±10 65±11 0.431a
gender (male) 81 (79) 147 (80) 0.403b
BMI 27.9±4.6 25.3±4.7 <0.001a
Duration of hospitalization (days) 3.1±3.6 2.1±2.7 0.007a
Risk factors
Currently smoking 25 (24) 52 (28) 0.535b
Family cardio anamnesis 18 (17) 34 (19) 0.942b
Cholesterol 0.89±0.31 0.75±0.43 0.003a
Hypertension 91 (88) 131 (72) 0.002b
Medication
Aspirin 93 (90) 152 (83) 0.134b
Clopidogrel 62 (60) 102 (56) 0.544b
In Ca 2+ 26 (25) 39 (21) 0.539b
ACE inhibitors 54 (52) 73 (40) 0.054b
Beta-blockers 77 (75) 109 (59) 0.016b
Nitrate 6 (6) 18 (10) 0.328b
Angiotensin antagonists 18 (17) 25 (14) 0.512b
Type of vessel
CD 19 (18) 42 (23) 0.005
CX 11 (11) 29 (16) 0.007
IVA 73 (71) 111 (61) 0.006
DM – diabetes mellitus patients, non-DM – non-diabetes mellitus patients, a – t-test for independent samples, b – chi-square test, RCA –
desna koronarna arterija, CX – zavijena grana lijeve koronarne arterije, LAD – prednja silazna grana lijeve koronarne arterije
TABLE 2
FFR DATA AND ANGIOGRAPHIC VARIABLES IN DIABETIC AND NON-DIABETIC PATIENTS
Variable
DM n=103
n (%) or X±SD
non-DM n=183
n (%) or X±SD
Statistics
pa
FFR base 0.90±0.06 0.94±0.05 <0.001
FFR hyper 0.79±0.09 0.82±0.09 0.009
% stenosis 50.6±11.3 47.5±10.7 0.022
MLD (mm) 1.32±0.38 1.42±0.43 0.076
Lesion length (mm) 14.06±7.47 13.15±7.15 0.326
Reference diameter (mm) 2.74±0.56 2.77±0.59 0.794
DM – diabetes mellitus patients, non-DM – non-diabetes mellitus patients, a – t-test for independent samples, FFR base – basal value of
FFR, FFR hyper – FFR after vasodilatation, MLD – minimal lumen diameter
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ference found between groups according to the exercise
SPECT test.
Concordances for detection of ischemia between FFR
and exercise SPECT are presented in Tables 4. and 5. Di-
agnostic values of FFR and exercise SPECT are pre-
sented in Table 6. The probability of identifying patients
with FFR<0.80 (sensitivity) with positive result on exer-
cise SPECT test is 76% in diabetic and 87% in non-dia-
betic patients. The ability to identify patients with FFR
0.80 (specificity) with negative result on exercise SPECT
test is 49% in diabetic and 67% in non-diabetic patients14.
The positive predictive value was 64% for diabetic and
59% for non-diabetic patients, i.e. the ability of exercise
SPECT test to recognize patients with FFR<0.80 (posi-
tive result on the exercise SPECT test) was not high,
there was a large number of false positive results in both
groups of patients. The negative predictive value was
63% for diabetic and 91% for non-diabetic patients, i.e.
the ability of exercise SPECT test to recognize the pa-
tients with FFR³0.80 (negative results on exercise SPECT
test) was lower for the diabetic patients than for the
non-diabetic patients, i.e. truly negative results were
identified in most cases of non-diabetic patients, but not
in diabetic patients.
The positive likelihood ratio is small in both groups;
the odds of having FFR<0.80 are 10% for diabetics and
20% for non-diabetics with a positive exercise SPECT re-
sult than in the group that has a negative exercise
SPECT result (2.64 vs. 1.48)15. Negative likelihood re-
sults are lower than 0.50, the odds of having FFR³0.80
are 15% for diabetics and 30% for non-diabetics greater
in the group of patients that have a negative exercise
SPECT test result,(0.49 vs.0.19). The concordance be-
tween the two methods was found, it was fair in diabetic
patients (k=0.25, 95% C.I. 0.06–0.45) and moderate in
non-diabetic patients (k=0.49, 95 % C.I. 0.36–0.62)16.
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TABLE 3
SUMMARY RESULTS OF FFR AND EXERCISE SPECT TEST
IN DIABETIC AND NON-DIABETIC PATIENTS
Variable
DM
N=103
N (%)
non-DM
N=183
N (%)
Statistics
pa
Exercise SPECT
negative 32 (31) 74 (40) 0.057
positive 60 (58) 80 (44)
not performed 11 (11) 29 (16)
FFR hyper
negative (³0.80) 47 (46) 122 (67) <0.001
positive (<0.80) 55 (53) 60 (33)
DM – diabetes mellitus patients, non-DM – non-diabetes melli-
tus patients, a – chi-square test, FFR hyper – FFR after vasodi-
latation
1.0
0.9
0.8
0.7
0.6
0.5
Excercise SPECT
F
F
R
Negative Positive
GROUP
Non-DM
DM
Fig. 1. Results of excercise SPECT and FFR tests in groups of
diabetes and non-diabetes patients.
TABLE 4
CONCORDANCE FOR DETECTION OF ISCHEMIA BETWEEN FFR
AND EXERCISE SPECT FOR DIABETES MELLITUS PATIENTS
FFR
<0.80 N (%) ³0.8 N (%)
Exercise
SPECT
Positive 38 (37) 21 (20)
Negative 12 (12) 20 (19)
TABLE 5
CONCORDANCE FOR DETECTION OF ISCHEMIA BETWEEN FFR
AND EXERCISE SPECT FOR NON-DIABETES MELLITUS
PATIENTS
FFR
<0.80 N (%) ³0.8 N (%)
Exercise
SPECT
Positive 47 (26) 33 (18)
Negative 7 (4) 67 (37)
TABLE 6
DIAGNOSTIC VALUES FOR EXERCISE SPECT
Diagnostic value
DM
N=103
% (95% C.I.)
non-DM
N=183
% (95% C.I.)
Sensitivity 76 (61–87) 87 (75–95)
Specificity 49 (32–65) 67 (57–76)
Positive predictive value 64 (51–76) 59 (47–70)
Negative predictive value 63 (44–79) 91 (81–96)
Positive likelihood ratio 1.48 (1.06–2.08) 2.64 (1.96–3.55)
Negative likelihood ratio 0.49 (0.27–0.88) 0.19 (0.10–0.39)
Kappa coefficient of
concordance
0.25 (0.06–0.45) 0.49 (0.36–0.62)
DM – diabetes mellitus patients, non-DM – non-diabetes melli-
tus patients
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Discussion and Conclusion
A high prevalence of DM in general population, a sig-
nificant risk of developing CAD in these patients and the
need of dependable identification of significant coronary
lesions in routine practice, all emphasise the potential
significance of presented results. Exercise SPECT is a
non-invasive method suitable for extensive use with well
known limitations that are defined by its sensitivity and
specificity17. Our finding, according to which SPECT
shows a significantly lower concordance with FFR in pa-
tients with DM than in patients without DM, addition-
ally identifies the limitations of this method. It also con-
firms previous results obtained by the comparison with
coronary angiography without the hemodynamic evalua-
tion. Namely, it is known that the diagnostic value of ex-
ercise SPECT in patients with DM is worse than in pa-
tients without DM. The sensitivity of this test varied in
different studies from 80–90%, while the specificity from
75–90% with the positive predictive value of 57–87%, and
the negative one of 85–95%17. The fact that according to
the available literature the testing of concordance of re-
sults of exercise SPECT and coronary angiography with
FFR measurements has not been conducted so far addi-
tionally emphasises the significance of our results. Dif-
ferences in the diagnostic value of exercise SPECT be-
tween patients without and those with DM, besides the
anatomical specificities of CAD, definitely depend on its
specific functional determinants. Namely, besides the
morphological presentation covered by the classic coro-
nary angiography, the FFR test also comprises the sensi-
tive functional test of the capability of vasodilatation of
the tested coronary branch. As CAD in patients with DM
involves a heavy impact of endothelial dysfunction, mi-
crocirculatory disorder and myocardial hypertrophy, the
heart muscle perfusion disorder in these patients can
also be present without a significant coronary stenosis18.
As scintigraphy is a functional diagnostic test, unlike the
coronary angiography without FFR, being exclusively a
morphologic method of presentation, the coronary angio-
graphy with FFR, used in our research, is the method
that combines the advantages of both tests. With regard
to the specificities of CAD in patients with DM, the con-
firmation of the above mentioned limitations of scinti-
graphy in these patients, which we carried out with the
FFR test, seem to be highly significant. Chamuleau et al.
have compared the specificity of myocardial SPECT per-
fusion with FFR and therewith showed that the inci-
dence of coronary events was significantly higher in the
group that on the basis of normal findings of perfusion
test did not undergo PCI despite significant values of
FFR (<0.75)19. The above mentioned emphasised the su-
periority of the FFR method in the identification of sig-
nificant coronary lesions and additionally confirms the
value of our results in their clinical interpretation. In our
research we did not use methods such as the exercise
ECG testing and stress echocardiography, which we do
not consider to be a significant limiting factor as their
sensitivity and specificity in detecting ischemic lesions in
patients with DM is defined as a low one, i.e. significantly
lower than that of the exercise SPECT that we used. Our
results obtained using combined morphological and func-
tional method with the confirmed high sensitivity and
specificity in detecting myocardial ischemia can thus be
transposed to confirmed limitations of the use of exercise
ECG testing and stress echocardiography in patients
with DM20. Furthermore, the conclusions of our research
confirm these limitations, as well as the frequent incon-
clusiveness and inappropriateness of noninvasive meth-
ods in patients with DM and suspected CAD.
The prospective DEFER study has shown that un-
treated lesions with FFR value of <0.75 are predictable
for higher incidence of adverse events during the five-
-year follow up21. With the aim to improve the sensitivity
of FFR and its better correlation with the scintigraphic
findings, we used the upper limit of FFR of 0.80 in our re-
search, so that what remains open is the issue of correla-
tion of methods in diabetics and non-diabetics at other
levels of defined limit values. The issue of defining differ-
ent limit values of the FFR measurement of the signifi-
cance of coronary lesions in groups with or without DM
is one of the theories that still needs to be tested.
Dominguez – Franco and collaborators tried to evalu-
ate the prognostic value of FFR in diabetics, following 40
patients during 30 months22. This number of patients
was too small for the observed differences to reach the
level of statistical significance, while the analysed coro-
nary lesions cannot represent typical changes in patients
with DM. Namely, the average diameter of analysed coro-
nary lesions measured 3 mm, which means that these
were only the changes in large epicardial coronary arter-
ies, while the rigorously selected patients regularly had
lesions of the focal character, i.e. it was not the case of
diffuse atherosclerotic disease typical of patients with
DM.
Although the presented results need a further confir-
mation in future research studies, they convincingly
point to a high limitation of exercise SPECT and empha-
sise the need for a wider application of FFR testing in
routine coronary angiography in patients with DM.
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ISHEMIJA MIOKARDA U BOLESNIKA SA [E]ERNOM BOLE[]U:
OGRANI^ENJA PERFUZIJSKIH PRIKAZA
S A @ E T A K
U istra`ivanju koje je obuhvatilo 286 pacijenata s utemeljenom sumnjom na koronarnu bolest i nedavno u~injenom
kompjutoriziranom jednostrukom emisionom fotonskom tomografijom (SPECT) u optere}enju, izveli smo koronarnu
angiografiju s izmjerom pri~uve frakcijskog protoka (FFR) kako bismo testirali postojanje razlike u detekciji miokardne
ishemije SPECT-om u bolesnika sa {e}ernom bole{}u (103) i bez nje (183). Dijabeti~ari su imali vi{u prevalenciju arte-
rijske hipertenzije, vi{i indeks tjelesne mase (ITM) i razine kolesterola, kao i du`u prosje~nu hospitalizaciju od nedija-
beti~ara. Rezultati SPECT-testa nisu pokazali zna~ajnih razlika izme|u skupina, dok su rezultati FFR-testa ukazali na
postojanje zna~ajno vi{e negativnih nalaza u nedijabeti~ara. Tako|er, FFR-test je u skupini dijabeti~ara iskazao zna-
~ajno vi{e stupnjeve koronarnih stenoza. Sukladnost uspore|ivanih metoda definirana je niskom u dijabeti~ara (k=
0,25, 95% C.I. 0,06–0,45) i umjerenom u nedijabeti~ara (k=0,49, 95% C.I. 0,36–0,62).
T. Jakljevi} et al.: Myocardial Ischemia Detection in Diabetic Patients, Coll. Antropol. 36 (2012) 3: 821–826
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